GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases

BACKGROUND: The French PRODIGE 7 trial, published on January 2021, has raised doubts about the specific survival benefit provided by HIPEC with oxaliplatin 460 mg/m(2) (30 minutes) for the treatment of peritoneal metastases from colorectal cancer. However, several methodological flaws have been iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Fernando, Serrano, Angel, Manzanedo, Israel, Pérez-Viejo, Estibalitz, González-Moreno, Santiago, González-Bayón, Luis, Arjona-Sánchez, Alvaro, Torres, Juan, Ramos, Isabel, Barrios, Maria E., Cascales, Pedro, Morales, Rafael, Boldó, Enrique, García-Fadrique, Alfonso, Arteaga, Xabier, Gutierrez-Calvo, Alberto, Sánchez-García, Susana, Asensio, Enrique, Ramírez, Cesar P., Artiles, Manuel, Vaqué, Javier, Parra, Pedro A., Villarejo, Pedro, Muñoz-Casares, Cristóbal, Turienzo, Estrella, Calero, Alicia, Torrejimeno, Isabel Jaén, Prieto, Isabel, Galindo, Julio, Borrego, Vicente, Marcello, Manuel E., Rihuete, Cristina, Carrasco, Joaquin, Gomez-Quiles, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097342/
https://www.ncbi.nlm.nih.gov/pubmed/35549912
http://dx.doi.org/10.1186/s12885-022-09572-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097342/
https://www.ncbi.nlm.nih.gov/pubmed/35549912
http://dx.doi.org/10.1186/s12885-022-09572-7

Ejemplares similares